Industry Information

Urokinase manufacturer describes its pharmacological actions

  Kangyuan is a professional Hormone API Manufacturer, which is your best choice. Let's introduce Urokinase manufacturer.

  Pharmacological effects of urokinase

Urokinase manufacturer describes its pharmacological actions

  This product acts directly on the endogenous fibrinolysis system, can catalyze the lysis of fibrinogen into fibrinolytic enzyme, the latter can not only degrade fibrinogen clots, but also degrade the fibrinogen, coagulation factor Ⅴ and coagulation factor in blood circulation, so as to play the role of thrombolysis. This product has a quick and good effect on newly formed thrombus. This product can also improve vascular ADP enzyme activity, inhibit ADP-induced platelet aggregation, prevent thrombosis. After intravenous infusion of the product, the activity of fibrinolytic enzyme in patients was significantly increased. A few hours after drug withdrawal, plasminase activity returned to its original level. However, the decrease in plasma fibrin or fibrinogen levels and the increase in their degradation products can last for 12 to 24 hours. Thrombolytic effect was significantly correlated with drug dose and time window of administration.

  The toxicity of this product is very low, and the 50% lethal dose of intravenous injection in mice is more than 1 million IU/kg body weight. There is no obvious antigenicity, teratogenicity, carcinogenicity and mutagenicity. Anaphylaxis is rarely reported in clinical application. However, since this product increases plasminogen activity and reduces unbound plasminogen and fibrin-bound plasminogen in circulation, there may be a serious risk of bleeding.

  If you want to know more, please follow us. We will update you regularly about Human Chorionic Gonadotropin, Human Menopausal Gonadotropin Supplier, Urofollitropin price, Urokinase manufacturer, Hormone API manufacturer. Hope to help you.